HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Predictive performance of a genetic risk score using 11 susceptibility alleles for the incidence of Type 2 diabetes in a general Japanese population: a nested case-control study.

AbstractAIMS:
To assess the predictive ability of a genetic risk score for the incidence of Type 2 diabetes in a general Japanese population.
METHODS:
This prospective case-control study, nested within a Japan Public Health Centre-based prospective study, included 466 participants with incident Type 2 diabetes over a 5-year period (cases) and 1361 control participants, as well as 1463 participants with existing diabetes and 1463 control participants. Eleven susceptibility single nucleotide polymorphisms, identified through genome-wide association studies and replicated in Japanese populations, were analysed.
RESULTS:
Most single nucleotide polymorphism loci showed directionally consistent associations with diabetes. From the combined samples, one single nucleotide polymorphism (rs2206734 at CDKAL1) reached a genome-wide significance level (odds ratio 1.28, 95% CI 1.18-1.40; P = 1.8 × 10-8 ). Three single nucleotide polymorphisms (rs2206734 in CDKAL1, rs2383208 in CDKN2A/B, and rs2237892 in KCNQ1) were nominally significantly associated with incident diabetes. Compared with the lowest quintile of the total number of risk alleles, the highest quintile had a higher odds of incident diabetes (odds ratio 2.34, 95% CI 1.59-3.46) after adjusting for conventional risk factors such as age, sex and BMI. The addition to the conventional risk factor-based model of a genetic risk score using the 11 single nucleotide polymorphisms significantly improved predictive performance; the c-statistic increased by 0.021, net reclassification improved by 6.2%, and integrated discrimination improved by 0.003.
CONCLUSIONS:
Our prospective findings suggest that the addition of a genetic risk score may provide modest but significant incremental predictive performance beyond that of the conventional risk factor-based model without biochemical markers.
AuthorsA Goto, M Noda, M Goto, K Yasuda, T Mizoue, T Yamaji, N Sawada, M Iwasaki, M Inoue, S Tsugane, JPHC Study Group
JournalDiabetic medicine : a journal of the British Diabetic Association (Diabet Med) Vol. 35 Issue 5 Pg. 602-611 (05 2018) ISSN: 1464-5491 [Electronic] England
PMID29444352 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2018 Diabetes UK.
Chemical References
  • C2CD4A protein, human
  • CDKN2A protein, human
  • CDKN2B protein, human
  • Cyclin-Dependent Kinase Inhibitor p15
  • Cyclin-Dependent Kinase Inhibitor p16
  • Cyclin-Dependent Kinase Inhibitor p18
  • HHEX protein, human
  • Homeodomain Proteins
  • IGFBP2 protein, human
  • IRS1 protein, human
  • Insulin Receptor Substrate Proteins
  • Insulin-Like Growth Factor Binding Protein 2
  • KCNQ1 Potassium Channel
  • KCNQ1 protein, human
  • Kir6.2 channel
  • Nuclear Proteins
  • PPAR gamma
  • Potassium Channels, Inwardly Rectifying
  • TCF7L2 protein, human
  • Transcription Factor 7-Like 2 Protein
  • Transcription Factors
  • Alpha-Ketoglutarate-Dependent Dioxygenase FTO
  • FTO protein, human
  • tRNA Methyltransferases
  • UBE2E2 protein, human
  • Ubiquitin-Conjugating Enzymes
  • CDKAL1 protein, human
Topics
  • Adult
  • Aged
  • Alpha-Ketoglutarate-Dependent Dioxygenase FTO (genetics)
  • Asian People (genetics)
  • Case-Control Studies
  • Cyclin-Dependent Kinase Inhibitor p15 (genetics)
  • Cyclin-Dependent Kinase Inhibitor p16
  • Cyclin-Dependent Kinase Inhibitor p18 (genetics)
  • Diabetes Mellitus, Type 2 (epidemiology, genetics)
  • Female
  • Genetic Predisposition to Disease
  • Homeodomain Proteins (genetics)
  • Humans
  • Incidence
  • Insulin Receptor Substrate Proteins (genetics)
  • Insulin-Like Growth Factor Binding Protein 2 (genetics)
  • Japan (epidemiology)
  • KCNQ1 Potassium Channel (genetics)
  • Male
  • Middle Aged
  • Nuclear Proteins (genetics)
  • PPAR gamma (genetics)
  • Potassium Channels, Inwardly Rectifying (genetics)
  • Prospective Studies
  • Risk Assessment
  • Risk Factors
  • Transcription Factor 7-Like 2 Protein (genetics)
  • Transcription Factors (genetics)
  • Ubiquitin-Conjugating Enzymes (genetics)
  • tRNA Methyltransferases (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: